Option Care Health (NASDAQ:OPCH) Stock Rating Upgraded by Bank of America

Bank of America upgraded shares of Option Care Health (NASDAQ:OPCH) from a neutral rating to a buy rating in a research note released on Monday morning, MarketBeat Ratings reports. Bank of America currently has $33.00 price objective on the stock, up from their previous price objective of $26.00.

Several other brokerages also recently weighed in on OPCH. Barrington Research cut their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $29.71.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $27.72 on Monday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $4.72 billion, a PE ratio of 23.29, a P/E/G ratio of 2.43 and a beta of 1.31. Option Care Health has a 1-year low of $21.39 and a 1-year high of $34.63. The business’s fifty day moving average price is $23.20 and its two-hundred day moving average price is $27.69.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Graypoint LLC acquired a new position in Option Care Health in the fourth quarter worth approximately $1,161,000. Harbor Capital Advisors Inc. boosted its stake in shares of Option Care Health by 2.7% during the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company’s stock worth $4,945,000 after acquiring an additional 5,595 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Option Care Health by 6.0% in the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company’s stock worth $2,165,000 after acquiring an additional 5,365 shares during the last quarter. Central Pacific Bank Trust Division raised its position in shares of Option Care Health by 6.9% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock worth $234,000 after purchasing an additional 650 shares during the period. Finally, TD Private Client Wealth LLC lifted its holdings in shares of Option Care Health by 21.4% during the third quarter. TD Private Client Wealth LLC now owns 5,723 shares of the company’s stock valued at $179,000 after purchasing an additional 1,007 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.